Clinical improvement of renal amyloidosis in a patient with systemic-onset juvenile idiopathic arthritis who received tocilizumab treatment: a case report and literature review
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical improvement of renal amyloidosis in a patient with systemic-onset juvenile idiopathic arthritis who received tocilizumab treatment: a case report and literature review
Authors
Keywords
Renal amyloidosis, Systemic-onset juvenile idiopathic arthritis, Tocilizumab
Journal
BMC Nephrology
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-05-12
DOI
10.1186/s12882-017-0573-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AA amyloidosis treated with tocilizumab: case series and updated literature review
- (2015) Alice Courties et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- MEFV Mutations in Egyptian Children with Systemic-Onset Juvenile Idiopathic Arthritis
- (2014) Hala M. Lotfy et al. Molecular Diagnosis & Therapy
- AA Amyloidosis Associated With Systemic-Onset Juvenile Idiopathic Arthritis
- (2013) Abhijeet Saha et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Comparison of the clinical utility of tocilizumab and anti-TNF therapy in AA amyloidosis complicating rheumatic diseases
- (2013) Yasuaki Okuda et al. Modern Rheumatology
- Pathophysiology and treatment of systemic amyloidosis
- (2013) Julian D. Gillmore et al. Nature Reviews Nephrology
- Good medium-term efficacy of tocilizumab in DMARD and anti-TNF-α therapy resistant reactive amyloidosis
- (2012) Markku Hakala et al. ANNALS OF THE RHEUMATIC DISEASES
- Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Fabrizio De Benedetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term TNF-α Blockade in Patients with Amyloid A Amyloidosis Complicating Rheumatic Diseases
- (2010) Antonio Fernández-Nebro et al. AMERICAN JOURNAL OF MEDICINE
- Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis
- (2010) Jean D. Sipe et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Rapid and complete resolution of ascites and hydrothorax due to nephrotic syndrome caused by renal amyloidosis in a patient with juvenile chronic arthritis treated with adalimumab
- (2009) Beata Nowak et al. JOINT BONE SPINE
- Is E148Q a Benign Polymorphism or a Disease-causing Mutation?
- (2009) D. MAREK-YAGEL et al. JOURNAL OF RHEUMATOLOGY
- Clinical Remission in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Anti-Tumor Necrosis Factor Agents
- (2009) R. A.G. RUSSO et al. JOURNAL OF RHEUMATOLOGY
- Systemic-onset juvenile idiopathic arthritis complicated by early onset amyloidosis in a patient carrying a mutation in the MEFV gene
- (2009) Luca Cantarini et al. RHEUMATOLOGY INTERNATIONAL
- Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
- (2008) Shumpei Yokota et al. LANCET
- MEFV mutations in systemic onset juvenile idiopathic arthritis
- (2008) N. A. Ayaz et al. RHEUMATOLOGY
- Amyloidosis—Recent Developments
- (2008) Tom Pettersson et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started